{"id":"https://openalex.org/W2107250831","doi":null,"title":"Review Article and Clinical Experiences: A NOVEL OAD WITH BROADSPEACTRUM THERAPEUTIC VALUE FOR PTS WITH T2DM The Roles of Galvus\u00ae for Pts with T2DM, MODY,TxDM, Pre-DM, and T1DM","display_name":"Review Article and Clinical Experiences: A NOVEL OAD WITH BROADSPEACTRUM THERAPEUTIC VALUE FOR PTS WITH T2DM The Roles of Galvus\u00ae for Pts with T2DM, MODY,TxDM, Pre-DM, and T1DM","publication_year":2009,"publication_date":"2009-07-01","ids":{"openalex":"https://openalex.org/W2107250831","mag":"2107250831"},"language":"en","primary_location":{"id":"mag:2107250831","doi":null,"is_oa":true,"landing_page_url":"http://journal.unair.ac.id/filerPDF/12%2008046%20Askandar%200842%20FMI%20edit.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210179714","display_name":"Folia Medica Indonesiana","issn_l":"2355-8393","issn":["2355-8393","2599-056X"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310315151","host_organization_name":"Airlangga University","host_organization_lineage":["https://openalex.org/P4310315151"],"host_organization_lineage_names":["Airlangga University"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Folia Medica Indonesiana","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://journal.unair.ac.id/filerPDF/12%2008046%20Askandar%200842%20FMI%20edit.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063812781","display_name":"Askandar Tjokroprawiro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Askandar Tjokroprawiro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5063812781"],"corresponding_institution_ids":[],"apc_list":{"value":1500000,"currency":"IDR","value_usd":98},"apc_paid":{"value":1500000,"currency":"IDR","value_usd":98},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"45","issue":"3","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.7360000014305115},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.6840000152587891},{"id":"https://openalex.org/keywords/exendin-4","display_name":"exendin-4","score":0.7239999771118164},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.875},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.7720000147819519},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.5370000004768372},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.609000027179718},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.718999981880188},{"id":"https://openalex.org/keywords/maturity-onset-diabetes-of-the-young","display_name":"maturity-onset diabetes of the young","score":0.7760000228881836},{"id":"https://openalex.org/keywords/prediabetes","display_name":"prediabetes","score":0.7369999885559082},{"id":"https://openalex.org/keywords/dpp-4-inhibition","display_name":"DPP-4 inhibition","score":0.6060000061988831},{"id":"https://openalex.org/keywords/glp-1-analogues","display_name":"GLP-1 analogues","score":0.5479999780654907}],"concepts":[{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.7654588222503662},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.7029623985290527},{"id":"https://openalex.org/C2780282729","wikidata":"https://www.wikidata.org/wiki/Q3121121","display_name":"Saxagliptin","level":5,"score":0.6774641871452332},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6672211289405823},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6560025811195374},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.6146623492240906},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.5818410515785217},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5447517037391663},{"id":"https://openalex.org/C2776129832","wikidata":"https://www.wikidata.org/wiki/Q22677256","display_name":"Gastric inhibitory polypeptide","level":4,"score":0.45947781205177307},{"id":"https://openalex.org/C2781469919","wikidata":"https://www.wikidata.org/wiki/Q5279728","display_name":"Dipeptidyl peptidase","level":3,"score":0.435515820980072},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.428352028131485},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4235232174396515},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.39813971519470215},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.3642370104789734},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.32601237297058105},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3103175163269043},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.29645872116088867},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2680118680000305},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.14168822765350342},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13211196660995483}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2107250831","doi":null,"is_oa":true,"landing_page_url":"http://journal.unair.ac.id/filerPDF/12%2008046%20Askandar%200842%20FMI%20edit.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210179714","display_name":"Folia Medica Indonesiana","issn_l":"2355-8393","issn":["2355-8393","2599-056X"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310315151","host_organization_name":"Airlangga University","host_organization_lineage":["https://openalex.org/P4310315151"],"host_organization_lineage_names":["Airlangga University"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Folia Medica Indonesiana","raw_type":null}],"best_oa_location":{"id":"mag:2107250831","doi":null,"is_oa":true,"landing_page_url":"http://journal.unair.ac.id/filerPDF/12%2008046%20Askandar%200842%20FMI%20edit.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210179714","display_name":"Folia Medica Indonesiana","issn_l":"2355-8393","issn":["2355-8393","2599-056X"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4310315151","host_organization_name":"Airlangga University","host_organization_lineage":["https://openalex.org/P4310315151"],"host_organization_lineage_names":["Airlangga University"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Folia Medica Indonesiana","raw_type":null},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1905803407","https://openalex.org/W1968676703","https://openalex.org/W1970406523","https://openalex.org/W1984588810","https://openalex.org/W2000465889","https://openalex.org/W2027249582","https://openalex.org/W2032322539","https://openalex.org/W2043121816","https://openalex.org/W2049323977","https://openalex.org/W2066861619","https://openalex.org/W2080128749","https://openalex.org/W2081666098","https://openalex.org/W2108282017","https://openalex.org/W2115428578","https://openalex.org/W2119114384","https://openalex.org/W2169558934","https://openalex.org/W2209729164"],"related_works":["https://openalex.org/W1902646265","https://openalex.org/W7096721119","https://openalex.org/W2035972962","https://openalex.org/W2064437324","https://openalex.org/W2146466098","https://openalex.org/W7048609817","https://openalex.org/W2080509524","https://openalex.org/W2118028598","https://openalex.org/W7029240889","https://openalex.org/W2621391367"],"abstract_inverted_index":{"Incretins,":[0],"or":[1,321],"gut":[2],"hormones":[3,289],"(glucagon-like":[4],"peptide-1":[5],"=":[6,12,276],"GLP-1,":[7,103],"and":[8,57,88,118,131,178,205,274,278,291,314,342,345,377],"glucose-dependent":[9],"insulinotropic":[10],"polypeptide":[11],"GIP),":[13],"exert":[14],"several":[15],"beneficial":[16,383],"effects":[17,384],"in":[18,50,185,248,268,319,322,324,372,385],"glycemic":[19,391],"control,":[20],"collectively":[21],"called":[22],"the":[23,30,33,62,80,105,147,152,162,180,186,219,251,287,295,306,309,364],"\u201cincretin":[24],"effect\u201d.":[25],"It":[26],"is":[27,77,108,141,159,201,231],"refers":[28],"to":[29,36,43,91,98,122,218,227,247,250,263],"amplification":[31],"of":[32,64,84,126,146,151,166,182,199,221,237,308,316,366],"insulin":[34],"response":[35],"glucose,":[37,210],"when":[38],"delivered":[39],"orally":[40],"as":[41,359],"opposed":[42],"intravenously":[44],"(Perley":[45],"et":[46,69,73,255,302],"al.":[47,70,74,256,303],"1967).":[48],"Studies":[49],"experimental":[51],"animals":[52],"have":[53],"demonstrated":[54],"that":[55,213,336,355],"GLP-1":[56,127,132,184,200,207,230,266],"GIP":[58,76,130],"are":[59,133,259],"needed":[60],"for":[61,298,363],"maintenance":[63],"normal":[65,204],"glucose":[66],"tolerance":[67],"(Scrocchi":[68],"1996;":[71],"Miyawaki":[72],"1999).":[75],"released":[78,109],"into":[79,110],"circulation":[81,111],"after":[82,113,136],"ingestion":[83],"a":[85,144,157,360],"meal;":[86],"fat":[87],"carbohydrates":[89],"seem":[90,120],"be":[92,99,123,334,357],"predominant":[93],"stimulators,":[94],"whereas":[95],"protein":[96,119],"seems":[97],"less":[100,238],"important.":[101],"The":[102,139,223],"on":[104,311,328],"other":[106,329,378],"hand,":[107],"minutes":[112,242],"meal":[114],"ingestion;":[115],"fat,":[116],"carbohydrates,":[117],"all":[121],"powerful":[124],"stimulators":[125],"secretion.":[128],"Both":[129],"rapidly":[134],"inactivated":[135],"their":[137,299],"release.":[138],"inactivation":[140],"caused":[142],"by":[143,149,161,168,293],"truncation":[145],"peptides":[148],"removal":[150],"N-terminal":[153],"dipeptide":[154],"end;":[155],"such":[156],"process":[158],"executed":[160],"enzyme":[163,296],"DPP-4.":[164],"Inhibition":[165],"DPP-4":[167,253,279],"gliptin":[169],"class":[170],"(vildagliptin,":[171],"sitagliptin,":[172],"saxagliptin)":[173],"substantially":[174],"prolongs":[175],"this":[176,214],"half-life":[177],"increases":[179],"proportion":[181],"active":[183],"total":[187],"GLp-1":[188],"pool.":[189],"In":[190],"patients":[191,325,388],"with":[192,374,389],"type":[193],"2":[194,240,260],"diabetes":[195],"mellitus":[196],"(T2DM),":[197],"secretion":[198],"lower":[202],"than":[203,239],"increasing":[206],"decreases":[208],"blood":[209],"which":[211,284],"suggest":[212],"hormone":[215],"may":[216,285],"contribute":[217],"pathogenesis":[220],"T2DM.":[222],"major":[224],"therapeutic":[225,369],"drawback":[226],"using":[228],"native":[229],"its":[232],"very":[233],"short":[234],"half":[235],"life":[236],"(two)":[241,261],"following":[243],"exogenous":[244],"administration,":[245],"due":[246],"part":[249],"protease":[252],"(Deacon":[254,301],"1995).":[257,304],"There":[258],"approaches":[262],"enhance":[264],"endogenous":[265],"action":[267],"vivo":[269],"Incretin":[270],"Mimetic":[271],"(GLP-1":[272,290],"Analogues":[273],"Exenatide":[275],"Exendin-4)":[277],"inhibitors":[280],"(Vildagliptin,":[281],"Sitagliptin,":[282],"Saxagliptin)":[283],"increase":[286],"incretin":[288],"GIP)":[292],"inhibiting":[294],"responsible":[297],"degradation":[300],"On":[305],"basis":[307],"data":[310],"efficacy,":[312],"safety,":[313],"tolerability":[315],"vildagliptin":[317,337],"either":[318],"monotherapy":[320,327],"combination,":[323],"failing":[326],"T2DM":[330],"treatments,":[331],"it":[332],"can":[333,356],"concluded":[335],"50":[338],"mg":[339,347],"once":[340,348],"daily":[341,349],"twice":[343],"daily,":[344],"100":[346],"show":[350],"1.":[352],"promising":[353],"regimen":[354],"used":[358,380],"novel":[361],"strategy":[362],"treatment":[365],"T2DM;":[367],"2.":[368],"value":[370],"if":[371],"combination":[373],"metformin,":[375],"glitazone,":[376],"commonly":[379],"OADs;":[381],"3.":[382],"diabetic":[386],"insulin-treated":[387],"inadequate":[390],"control.":[392]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}